A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
for Schizophrenia
Drug: KarXT
Sites in Columbia +50 more locations
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All·Age: 5 - 17
Code: NCT07424404·Phase 3·Recruiting·Listed Feb 2026